Trusted Resources: News & Meetings
Latest announcements and gatherings
FDA Drug Safety Communication: New Boxed Warning on Severe Liver Injury With Propylthiouracil
The United States Food and Drug Administration (FDA) has added a Boxed Warning to the label for propylthiouracil, a drug used to treat hyperthyroidism (overactive thyroid), to include information about reports of severe liver injury and acute liver failure, some of which have been fatal, in adult and pediatric patients using this medication.
The new warning also states that for patients being started on treatment for hyperthyroidism it may be appropriate to reserve use of propylthiouracil for those who cannot tolerate other treatments such as methimazole, radioactive iodine or surgery. In addition, due to the occurrence of birth defects that have been observed with the use of methimazole during the first trimester of pregnancy, propylthiouracil may be the treatment of choice during and just before the first trimester of pregnancy.
myBinderRelated Content
-
Hepatic Dysfunction Related to Thyrotropin Receptor Antibody in Patients With Graves’ DiseaseBackground: Hepatic dysfunction is a co...
-
Successful Re-Administration of Low-Dose of Methimazole (MMI) in Graves’ Disease Patients who Experienced Alle...Objective: When patients with Graves' d...
-
Risk Factors of Hepatic Dysfunction in Patients With Graves’ Hyperthyroidism and the Efficacy of 131iodine Tre...Hepatic dysfunction is often observed in...
-
“TED Today” Episode 5https://www.facebook.com/ThyroidEyes/vid...
-
The University of Texas Southwestern Medical CenterThe specialized endocrinologists and end...
-
University of Minnesota – Center for Thyroid Eye DiseaseIf you experience dry or watery eyes, re...
-
Gail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Communityhttps://www.youtube.com/watch?v=ep3ArKFb...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Facebook
Google